Vimarsana
Biggest News Aggregation in the World

Expand Label News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expand Label. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expand Label Today - Breaking & Trending Today

European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2 - Vimarsana News

European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2

Published: January 3, 2023

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,...

Source: prnewswire.com
Related Topics:
Hank FuchsTraci MccartyEuropean CommissionDrug AdministrationBiomarin Pharmaceutical IncExchange CommissionWorldwide ResearchHealth AuthoritiesPrnewswire Biomarin Pharmaceutical IncEuropean Medicines AgencyEu European Union Summary Of Product CharacteristicsExpand LabelTreat ChildrenAchondroplasia UnderFavorable ResultsGlobal Randomized PhaseYoung Children Demonstrating IncreaseGrowth VelocityAll CohortsBenefit MoreHealth Authorities ExpectedMarin PharmaceuticalNew Drug ApplicationSerious Adverse EventsSafety Information
European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2 - Vimarsana News

European Medicines Agency Validates Application for Extension of Indication for VOXZOGO® (vosoritide) for injection to Treat Children with Achondroplasia Under the Age of 2

Published: January 3, 2023

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,...

Source: prnewswire.com
Related Topics:
Hank FuchsTraci MccartyEuropean CommissionDrug AdministrationBiomarin Pharmaceutical IncExchange CommissionWorldwide ResearchHealth AuthoritiesPrnewswire Biomarin Pharmaceutical IncEuropean Medicines AgencyEu European Union Summary Of Product CharacteristicsExpand LabelTreat ChildrenAchondroplasia UnderFavorable ResultsGlobal Randomized PhaseYoung Children Demonstrating IncreaseGrowth VelocityAll CohortsBenefit MoreHealth Authorities ExpectedMarin PharmaceuticalNew Drug ApplicationSerious Adverse EventsSafety Information